These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1897195)

  • 21. Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide.
    Nair NP; Ahmed SK; Kin NM
    J Psychiatry Neurosci; 1993 Nov; 18(5):214-25. PubMed ID: 7905288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Moclobemide (Aurorix). A new monoamine oxidase inhibitor not requiring dietary restrictions].
    Larsen JK
    Ugeskr Laeger; 1991 Feb; 153(6):449-52. PubMed ID: 2000658
    [No Abstract]   [Full Text] [Related]  

  • 24. The therapeutic effect of moclobemide, a reversible selective monoamine oxidase A inhibitor, in Parkinson's disease.
    Sternic N; Kacar A; Filipovic S; Svetel M; Kostic VS
    Clin Neuropharmacol; 1998; 21(2):93-6. PubMed ID: 9579294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, conformational analysis and antidepressant activity of moclobemide new analogues.
    Ghanbarpour A; Hadizadeh F; Piri F; Rashidi-Ranjbar P
    Pharm Acta Helv; 1997 Apr; 72(2):119-22. PubMed ID: 9112832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiolytic and memory improving effects of moclobemide.
    Nowakowska E; Chodera A; Kus K; Rybakowski J
    Arzneimittelforschung; 1998 Jun; 48(6):625-8. PubMed ID: 9689417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some basic aspects of reversible inhibitors of monoamine oxidase-A.
    Da Prada M; Kettler R; Burkard WP; Lorez HP; Haefely W
    Acta Psychiatr Scand Suppl; 1990; 360():7-12. PubMed ID: 2248079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of monoamine oxidase by viloxazine in rats.
    Martinez C; Dominiak P; Kees F; Grobecker H
    Arzneimittelforschung; 1986 May; 36(5):800-3. PubMed ID: 2425816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine oxidase inhibitors and anesthesia: an updated literature review.
    Blom-Peters L; Lamy M
    Acta Anaesthesiol Belg; 1993; 44(2):57-60. PubMed ID: 8237297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moclobemide for depression.
    Drug Ther Bull; 1994 Jan; 32(1):6-8. PubMed ID: 7635005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modification of mitochondrial monoamine oxidase activity by certain amine inhibitors].
    Baumanis EA; Kalninia IE; Iriste AA; Gorkin VZ
    Vopr Med Khim; 1981; 27(1):72-7. PubMed ID: 6781140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Poisoning with a reversible and selective monoaminooxidase inhibitor].
    Pall M; Bested KM; Eriksen ND
    Ugeskr Laeger; 1997 Aug; 159(32):4859-60. PubMed ID: 9273760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hydrazine derivative modification of the activity of brain mitochondrial monoamine oxidases].
    Kalninia IE; Baumanas EA; Kaĭrane ChB; Gorkin VZ
    Vopr Med Khim; 1981; 27(6):773-9. PubMed ID: 7336653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhibition of brain monoamine oxidase in the rat by multiple pyrazidol administration].
    Verevkina IV; Asnina VV; Gorkin VZ; Mashkovskiĭ MD
    Biull Eksp Biol Med; 1985 May; 99(5):583-4. PubMed ID: 4005414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of brain monoamine oxidase by 1,2,4-trisubstituted 5-imidazolones.
    Kumar S; Pandey BR; Parmar SS; Gallagher JR; Mayer GG
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):163-6. PubMed ID: 6729247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The modification of the catalytic activity of mitochondrial monoaminoxidase and the suppression of the growth of experimental brain tumors].
    Baumanis EA; Gorkin VZ; Lisianyĭ NI; Kozhukhov AN
    Patol Fiziol Eksp Ter; 1990; (4):32-5. PubMed ID: 2080083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of benzamide derivatives on convulsions induced by the toxic action of oxygen in rats].
    Gol'dina OA; Tepliakov VG; Demurov EA; Koloskov IuB; Zagorevskiĭ VA
    Biull Eksp Biol Med; 1987 Oct; 104(10):469-71. PubMed ID: 3676473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
    Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
    J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of moclobemide.
    Haefely W; Burkard WP; Cesura A; Colzi A; Kettler R; Lorez HP; Martin JR; Moreau JL; Richards JG; Schaffner R
    Clin Neuropharmacol; 1993; 16 Suppl 2():S8-18. PubMed ID: 8313402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.